Drug Discovery

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced a multi-year collaboration with the…

Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, announces the acquisition of the…

ArrePath, an anti-infective drug discovery company addressing the global health challenge of drug resistant infections, announced that it has raised…

CytoReason, a leading developer of computational disease models for efficient drug discovery and development, announced the extension of its…

insitro, a machine learning-driven drug discovery and development company, announced the expansion of its leadership team with the appointments of…

With New Funding Curi Bio will Advance 3D Engineered Muscle Tissue Products for Drug Discovery Curi Bio Inc., a leading developer of human stem…

InveniAI LLC, a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and development, and…

20n Bio (20n), an artificial intelligence (AI)-powered drug discovery company focusing on designing new proteins for therapeutics, has raised a $3.3…

Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research Appian announced that it has…

Expansion of existing collaboration will leverage InveniAI technology to identify, evaluate, and optimize novel targets for Kyowa Kirin’s antibody…